EIR Sovereign Pharmaceuticals Oct 2002

David Beltran FDA, Daniel Lahar FDA$595.00 - Available Now

FDA investigators audited the Sovereign Pharmaceuticals - Fort Worth, TX, United States facility and issued inspectional observation (via FDA 483) on 24 Oct 2002.

Product details

  • Category:
  • Inspection end: 24 Oct 2002
  • Location: Fort Worth, United States
  • FEI: 3003229412
Add To Cart